Venous Thromboembolism Care
Studies on prevention strategy, risk scoring, recurrence management, and integrated follow up models in acute and chronic settings.
Call For Papers
Call for Clinically Relevant Evidence in Thrombosis and Treatments
The Journal of Thrombosis and Treatments invites submissions that improve prevention, diagnosis, risk stratification, treatment pathways, and long term outcomes across thrombotic disease care. We welcome original studies, implementation analyses, translational insights, and policy informed evaluations from hematologists, cardiologists, vascular specialists, neurologists, pharmacists, and multidisciplinary care teams. Manuscripts should offer methodological rigor, practical relevance, and clear implications for real clinical settings.
Rigorous - Review StandardsCanonical Metric
Fast - Publication ProcessCanonical Metric
Global - Research CommunityCanonical Metric
Open - Access PublicationCanonical Metric
Priority Submission Tracks
Current editorial priorities focus on evidence that supports decision quality in high risk thrombosis pathways.
Anticoagulation Management
Comparative studies of anticoagulant selection, dose strategy, adherence support, and safety monitoring in diverse populations.
Pulmonary Embolism Pathways
Risk stratification workflows, imaging and biomarker integration, escalation criteria, and care model optimization for PE management.
Arterial Thrombosis and Stroke
Evidence on antithrombotic strategy, secondary prevention, and multidisciplinary care coordination for arterial events.
Interventional and Device Contexts
Thrombosis related outcomes in catheter care, stent pathways, peri procedural management, and post intervention surveillance.
Implementation and Health Systems
Service redesign, protocol adoption, quality indicators, and policy interventions that improve thrombosis care reliability.
What Improves Editorial Outcomes
High performing submissions clearly define clinical context, patient population, intervention logic, and measurable outcomes. Editors prioritize manuscripts where conclusions remain proportional to data strength and limitations are discussed transparently. For implementation studies, operational feasibility and transferability should be addressed explicitly.
Strong papers also demonstrate complete ethics documentation, coherent statistical methodology, and practical discussion framing that supports real world decision making for thrombosis care teams.
Submission Package Essentials
- Structured abstract with objective, methods, results, and conclusion.
- Complete ethics and consent declarations where applicable.
- Transparent outcome definitions and statistical reporting.
- Clean references with DOI details where available.
- Cover letter explaining fit with thrombosis treatment priorities.
Use specific clinical terminology in title and keywords to improve reviewer matching and discoverability.
Editorial Route and Timeline Logic
We maintain a structured pathway that balances speed with methodologically sound decision quality.
Triage Review
Initial checks confirm scope fit, ethics readiness, and reporting completeness before full peer review assignment.
Expert Peer Review
Specialist reviewers evaluate validity, clinical relevance, and interpretation quality with structured recommendations.
Revision Round
Authors receive clear decision communication and focused revision priorities for efficient quality improvement.
Final Production
Accepted manuscripts proceed to technical production, metadata processing, and open access release.
Pre submission option: if your manuscript sits between thrombosis subdomains, contact the editorial office for a scope fit check before upload.
Frequently Raised Questions During Active Calls
These are common decision points for authors preparing thrombosis focused manuscripts.
Are negative or neutral trial findings welcome?
Yes. Methodologically strong studies with neutral findings are important for clinical decision quality and are fully considered.
Can single center studies be submitted?
Yes, if design quality is solid and limitations are discussed with realistic claims about external transferability.
Do you accept mixed clinical and implementation analyses?
Yes. Combined designs are welcome when methods and objective boundaries are reported clearly.
Can early career authors submit as corresponding author?
Yes. Submission quality and scientific merit drive decisions, not seniority status.
Manuscript Positioning That Converts to Better Decisions
Call for papers submissions perform best when they define clinical relevance and implementation value in explicit terms. To strengthen editorial outcomes, include a clear statement of how your results change diagnosis logic, treatment choice, risk monitoring, or care coordination in thrombosis practice. Reviewers respond more positively when manuscripts provide practical decision context alongside methodological rigor.
Clinical Decision Utility
Explain what clinicians can do differently after reading your study and under what conditions the recommendations apply.
Operational Transferability
Discuss resource requirements, pathway dependencies, and implementation limits so health systems can assess adoption feasibility.
Evidence Boundaries
Identify where conclusions are strong and where uncertainty remains, especially for subgroup interpretation.
Policy Relevance
When appropriate, describe implications for protocol design, quality metrics, and service level governance.
Author Positioning for Stronger Acceptance Probability
Submissions are most competitive when they explicitly connect evidence to clinical decisions. Clarify what treatment pathway, risk assessment step, or service protocol your findings improve. Manuscripts that define practical actionability and transferability conditions tend to receive clearer reviewer support and fewer major revision loops.
Explicit implementation value plus strong methods is the most reliable combination for high quality call-for-papers outcomes.
Well framed manuscripts define one clear clinical decision impact and one practical implementation boundary.
Submission Readiness Signal
Manuscripts that combine clear endpoints, realistic implementation context, and transparent limitations are consistently easier to review and more likely to move efficiently through decision cycles. Prioritize precision over promotional language and keep conclusions proportional to available evidence.
Practical and methodologically transparent manuscripts are prioritized for efficient handling.
Respond to the Current Call For Papers
Submit your thrombosis manuscript through the method that fits your workflow. If needed, request pre submission scope guidance from our team.
